BRIEF

on BASTIDE (EPA:BLC)

Bastide Group Finalizes Sale of EXPERF to Sapio Group

Stock price chart of BASTIDE (EPA:BLC) showing fluctuations.

On June 1, 2026, Bastide Group announced the completion of the sale of New Medical Concept, the holding company of the French EXPERF Group, to Sapio Group. This agreement was signed on May 21, 2026, and all necessary conditions were met by the end of May.

Vincent Bastide, CEO of Bastide Group, emphasized that the sale aligns with their strategic goals, allowing them to focus on more critical areas of their business while strengthening their financial structure. The transaction supports their pursuit of sustainable and profitable growth.

Mario Paterlini, CEO of Sapio Group, stated that acquiring EXPERF aligns with their strategy for sustainable growth in Europe, particularly in the healthcare sector. The acquisition is expected to bolster Sapio's presence in France significantly.

R. H.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all BASTIDE news